{"nct_id":"NCT02928224","title":"Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2016-10-13","start_date_type":"ACTUAL","primary_completion_date":"2019-02-11","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}